每周股票复盘：易明医药（002826）获1000万政府补助，董事减持9.4万股

Core Viewpoint - Yiming Pharmaceutical (002826) has shown a slight increase in stock price and received a significant government subsidy, which is expected to positively impact its financial performance in 2025 [1][2]. Company Stock Performance - As of March 28, 2025, Yiming Pharmaceutical's stock closed at 11.01 yuan, up 0.18% from the previous week, with a weekly high of 11.18 yuan and a low of 10.25 yuan [1]. - The company's current total market capitalization is 2.124 billion yuan, ranking 143rd out of 152 in the chemical pharmaceutical sector and 4736th out of 5140 in the A-share market [1]. Shareholder Changes - On April 1, 2025, the company's board approved the reduction of 94,000 shares, representing 0.0493% of the total share capital, during which the stock price increased by 3.62% [1][2]. Government Subsidy Announcement - Yiming Pharmaceutical received a government subsidy of 10 million yuan from the Lhasa Economic and Technological Development Zone Management Committee, which accounts for 64.99% of the company's audited net profit attributable to shareholders for 2023 [1]. - This subsidy is expected to increase the company's total profit for 2025 by 10 million yuan, subject to the final audit results [1][2].